EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cohort profile: SUPER-Finland – the Finnish study for hereditary mechanisms of psychotic disorders

Markku Lähteenvuo iD, Ari Ahola-Olli iD, Kimmo Suokas iD, Minna Holm, Zuzanna Misiewicz, Tuomas Jukuri, Teemu Männynsalo, Asko Wegelius, Willehard Haaki, Risto Kajanne, Aija Kyttälä, Annamari Tuulio-Henriksson und 16 weitere

BMJ Open · 2023-04 · 13 (4) · e070710

DOI: 10.1136/bmjopen-2022-070710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMJ Open, online erschienen am 12.04.2023. Verfasst von Markku Lähteenvuo und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland markku.lahteenvuo@niuva.fi. Hauptthemen laut MEDLINE: Psychotic Disorders, Schizophrenia, Bipolar Disorder. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Stanley Center for Psychiatric Research, The Academy of Finland Center of Excellence in Complex Disease Genetics, The Sigrid Juselius Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

SUPER-Finland is a large Finnish collection of psychosis cases. This cohort also represents the Finnish contribution to the Stanley Global Neuropsychiatric Genetics Initiative, which seeks to diversify genetic sample collection to include Asian, Latin American and African populations in addition to known population isolates, such as Finland.

Participants

10 474 individuals aged 18 years or older were recruited throughout the country. The subjects have been genotyped with a genome-wide genotyping chip and exome sequenced. A subset of 897 individuals selected from known population sub-isolates were selected for whole-genome sequencing. Recruitment was done between November 2015 and December 2018. Findings to date 5757 (55.2%) had a diagnosis of schizophrenia, 944 (9.1%) schizoaffective disorder, 1612 (15.5%) type I or type II bipolar disorder, 532 (5.1 %) psychotic depression, 1047 (10.0%) other psychosis and for 530 (5.1%) self-reported psychosis at recruitment could not be confirmed from register data. Mean duration of schizophrenia was 22.0 years at the time of the recruitment. By the end of the year 2018, 204 of the recruited individuals had died. The most common cause of death was cardiovascular disease (n=61) followed by neoplasms (n=40). Ten subjects had psychiatric morbidity as the primary cause of death. Future plans Compare the effects of common variants, rare variants and copy number variations (CNVs) on severity of psychotic illness. In addition, we aim to track longitudinal course of illness based on nation-wide register data to estimate how phenotypic and genetic differences alter it.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Psychotic DisordersSchizophreniaBipolar DisorderHumansFinlandDNA Copy Number Variations

Stichwörter der Autor:innen

Depression & mood disordersPSYCHIATRYSchizophrenia & psychotic disorders

Autor:innen und Institutionen

  • Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland markku.lahteenvuo@niuva.fi.
  • Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Faculty of Social Sciences, Tampere University, Tampere, Finland.
  • Finnish Institute for Health and Welfare, Helsinki, Finland.

ORCID-Profile: Markku Lähteenvuo, Ari Ahola-Olli, Kimmo Suokas

Förderung

  • The Stanley Center for Psychiatric Research
  • The Academy of Finland Center of Excellence in Complex Disease Genetics
  • The Sigrid Juselius Foundation

Zitieren

APA

Lähteenvuo, M., Ahola-Olli, A., Suokas, K., Holm, M., Misiewicz, Z., Jukuri, T., Männynsalo, T., Wegelius, A., Haaki, W., Kajanne, R., Kyttälä, A., Tuulio-Henriksson, A., Lahdensuo, K., Häkkinen, K., Hietala, J., Paunio, T., Niemi-Pynttäri, J., Kieseppä, T., Veijola, J., …, & Palotie, A. (2023). Cohort profile: SUPER-Finland – the Finnish study for hereditary mechanisms of psychotic disorders. BMJ Open, 13(4), e070710. https://doi.org/10.1136/bmjopen-2022-070710

Vancouver

Lähteenvuo M, Ahola-Olli A, Suokas K, Holm M, Misiewicz Z, Jukuri T, et al. Cohort profile: SUPER-Finland – the Finnish study for hereditary mechanisms of psychotic disorders. BMJ Open. 2023;13(4):e070710. doi:10.1136/bmjopen-2022-070710

BibTeX
@article{Lhteenvuo2023,
  author = {Lähteenvuo, Markku and Ahola-Olli, Ari and Suokas, Kimmo and Holm, Minna and Misiewicz, Zuzanna and Jukuri, Tuomas and Männynsalo, Teemu and Wegelius, Asko and Haaki, Willehard and Kajanne, Risto and Kyttälä, Aija and Tuulio-Henriksson, Annamari and Lahdensuo, Kaisla and Häkkinen, Katja and Hietala, Jarmo and Paunio, Tiina and Niemi-Pynttäri, Jussi and Kieseppä, Tuula and Veijola, Juha and Lönnqvist, Jouko and Isometsä, Erkki and Kampman, Olli and Tiihonen, Jari and Hyman, Steven and Neale, Benjamin and Daly, Mark and Suvisaari, Jaana and Palotie, Aarno},
  title = {Cohort profile: SUPER-Finland – the Finnish study for hereditary mechanisms of psychotic disorders},
  journal = {BMJ Open},
  year = {2023},
  volume = {13},
  number = {4},
  pages = {e070710},
  doi = {10.1136/bmjopen-2022-070710}
}
Kostenlos starten →